Loading…
Based on limited metadata, the FDA issued a warning letter to Luen Wah (HK) Medicine Ltd on April 6, 2018, regarding products classified outside standard drug or device categories. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The issuing office is not identified in the metadata provided, limiting clarity on the specific regulatory pathway or product jurisdiction involved. Additional documentation would be needed to characterize the specific compliance issues cited.